Condition: Heterozygous Familial Hypercholesterolemia (HeFH) · Sponsor: Merck Sharp & Dohme LLC
This study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with heterozygous familial hypercholesterolemia (HeFH) and high amounts of low-density lipoprotein cholesterol (LDL-C) in the blood. The goals of this study are to learn about the safety of enlicitide and if children tolerate it, what happens to enlicitide in a child's body over time, and if enlicitide works to lower cholesterol levels in children more than a placebo.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Nemours/Alfred I. duPont Hospital for Children ( Site 0001) | Wilmington, Delaware, United States | Recruiting |
| Children's National Medical Center ( Site 0015) | Washington D.C., District of Columbia, United States | Recruiting |
| Excel Medical Clinical Trials ( Site 0008) | Boca Raton, Florida, United States | Recruiting |
| Children's Healthcare of Atlanta Cardiology ( Site 0026) | Atlanta, Georgia, United States | Recruiting |
| Boston Children's Hospital ( Site 0018) | Boston, Massachusetts, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center ( Site 0016) | Cincinnati, Ohio, United States | Recruiting |
| West Virginia University ( Site 0013) | Morgantown, West Virginia, United States | Recruiting |
| Monash Children s Hospital ( Site 1603) | Clayton, Victoria, Australia | Recruiting |
| UZ Antwerpen ( Site 0601) | Edegem, Antwerpen, Belgium | Recruiting |
| Universidade Federal Do Ceara ( Site 0201) | Fortaleza, Ceará, Brazil | Recruiting |
| Instituto Dante Pazzanese de Cardiology ( Site 0206) | São Paulo, Brazil | Recruiting |
| Incor - Instituto do Coracao ( Site 0200) | São Paulo, Brazil | Recruiting |
+ 24 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07058077